A reduced β2-AR responsiveness in asthma may be the result of activation of the β2-AR by specific agonists (homologous desensitization) or activation of other receptors by the inflammatory mediators, which are present in the asthmatic airways (heterologous desensitization) [33]. The gene discussed is ADRB2; the disease is asthma.